Details for New Drug Application (NDA): 020947
✉ Email this page to a colleague
The generic ingredient in PENNSAID is diclofenac sodium. There are forty-seven drug master file entries for this compound. One hundred and twenty-nine suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.
Summary for 020947
Tradename: | PENNSAID |
Applicant: | Nuvo Pharms Inc |
Ingredient: | diclofenac sodium |
Patents: | 4 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Nov 4, 2009 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jul 10, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF TOPICAL DICLOFENAC ON THE KNEE AND A SECOND TOPICAL MEDICATION ON THE SAME KNEE | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 9, 2030 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | COMBINATION USE OF TOPICAL DICLOFENAC ON THE KNEE AND ADMINISTRATION OF AN ORAL NSAID. | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Aug 9, 2030 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF TOPICAL DICLOFENAC ON THE KNEE AND A SECOND TOPICAL AGENT SELECTED FROM SUNSCREEN AND INSECT REPELLANT |
Complete Access Available with Subscription